Diabetic Peripheral Neuropathy
📧 Sign up to get email alerts when something new happens for Diabetic Peripheral Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy [Phase 2]
A Phase 2 study assessing the analgesic effects of tanezumab in adults with diabetic peripheral neuropathy was terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy [Phase 3]
Phase 3 trial investigating pregabalin versus placebo for neuropathic pain in diabetic peripheral neuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Safety of Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy [Phase 4]
Phase 4 trial update assessing safety of pregabalin for pain due to diabetic peripheral neuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy [Phase 2]
A Phase 2 clinical trial update for treatment of neuropathic pain associated with diabetic peripheral neuropathy has completed with results …
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Electrical Stimulation for Improving Balance in Diabetes [NA]
Completed clinical trial investigating electrical stimulation to improve balance in diabetic peripheral neuropathy; results posted in 2020.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy [Phase 2, Phase 3]
Clinical trial updates show Phase 2 and Phase 3 testing of topical lidocaine to reduce pain in diabetic peripheral neuropathy; results poste…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 trial updates the efficacy and safety of NYX-2925 for diabetic peripheral neuropathy, with results posted after completion.
-
FDA approval · 2020-03-20FDA Approved: PREGABALIN — Original Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC's original ANDA for pregabalin, establishing a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 clinical trial update for pain associated with diabetic peripheral neuropathy. Study completed with results posted.
-
FDA approval · 2019-12-13FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental abbreviated new drug application for duloxetine hydrochloride from Aurobindo Pharma Limited (ANDA 090778), e…
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 clinical trial update evaluating a water-soluble sublingual CBD tablet for pain associated with diabetic neuropathy has completed.
-
FDA approval · 2019-11-29FDA Approved: PREGABALIN — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the original ANDA for pregabalin from Sun Pharmaceutical Industries, authorizing a generic version of pregabalin.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: A Randomized Controlled Trial to Assess the Effect of L-carnitine in Patients With Diabetic Peripheral Neuropathy to Relief Pain and Symptom Improvement [Phase 2]
Phase 2 randomized trial evaluating L-carnitine for relief of pain and symptom improvement in diabetic peripheral neuropathy.
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Electrical Stimulation in Diabetic Peripheral Neuropathy [NA]
Clinical trial update for electrical stimulation in diabetic peripheral neuropathy; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Study of PEMF to Evaluate VPT and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy [NA]
Completed clinical trial evaluating PEMF device effects on vibration perception threshold and thermal sensory in diabetic peripheral neuropa…
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Cipla USA, Inc.)
FDA approves Cipla USA, Inc.'s original application for pregabalin, granting a generic version of the drug for its established indications.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approves ScieGen Pharmaceuticals' original application for pregabalin (generic pregabalin), enabling the generic product to be marketed …
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (AvPAK)
FDA approved AvPAK's original application for pregabalin, enabling the generic version to enter the market.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for pregabalin (generic) submitted by Rising Pharma Holdings, Inc., authorizing its market authorizati…
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' generic pregabalin under ANDA207623 (original application), providing a generic version of pregabalin.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals' original ANDA for pregabalin, enabling a generic version of pregabalin to be marketed. The approva…
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's original ANDA for pregabalin, a generic version of Lyrica, for use in the United States. Th…
-
FDA approval · 2019-05-22FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for a generic duloxetine from Zydus Lifesciences Limited, authorizing marketing of the product.
-
FDA approval · 2019-04-17FDA Approved: DULOXETINE — Original Application (Qingdao BAHEAL Pharmaceutical Co., Ltd.)
FDA approved a generic version of duloxetine from Qingdao BAHEAL Pharmaceutical Co., Ltd. under an Original Application (ANDA 210599). The a…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Pharmacokinetics of Two Formulation of Pregabalin [Phase 4]
Phase 4 pharmacokinetic study comparing two formulations of pregabalin has been completed, evaluating effects in diabetic peripheral neuropa…